Resveratrol for primary prevention of atherosclerosis: Clinical trial evidence for improved gene expression in vascular endothelium

International Journal of Cardiology

Volumn 166, Issue 1, 2013, Pages 246-248

  Agarwal, Beamon ^a   Campen, Matthew J ^b   Channell, Meghan M ^b   Wherry, Sarah J ^c,d   Varamini, Behzad ^a   Davis, James G ^a   Baur, Joseph A ^a   Smoliga, James M ^c,e  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF NEW MEXICO   (United States)

^c MARYWOOD UNIVERSITY   (United States)

^d ARIZONA STATE UNIVERSITY   (United States)

^e HIGH POINT UNIVERSITY   (United States)

Author keywords

Adhesion molecule; Biomarker; Inflammation; Insulin; Polyphenol; Red wine

Indexed keywords

GAMMA INTERFERON; GRAPESKIN EXTRACT; INSULIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LEPTIN; PLACEBO; PLANT EXTRACT; QUERCETIN; RESVERATROL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ATHEROSCLEROSIS; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG RESPONSE; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; INTERCELLULAR ADHESION MOLECULE GENE; INTERLEUKIN 8 GENE; LETTER; PRIMARY PREVENTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; VASCULAR CELL ADHESION MOLECULE GENE; VASCULAR ENDOTHELIUM;

EID: 84877786892     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.09.027     Document Type: Article

References (9)

1. J.M. Smoliga, J.A. Baur, and H.A. Hausenblas Resveratrol and health - a comprehensive review of human clinical trials Mol Nutr Food Res 55 2011 1129 1141
2. J.A. Baur, and D.A. Sinclair Therapeutic potential of resveratrol: the in vivo evidence Nat Rev Drug Discov 5 2006 493 506
3. C. Schmidt, J. Hulthe, and B. Fagerberg Baseline ICAM-1 and VCAM-1 are increased in initially healthy middle-aged men who develop cardiovascular disease during 6.6 years of follow-up Angiology 60 2009 108 114
4. P. Greenland, J.S. Alpert, and G.A. Beller 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation 122 2010 e584 e636
5. G. Luc, D. Arveiler, and A. Evans Circulating soluble adhesion molecules ICAM-1 and VCAM-1 and incident coronary heart disease: the PRIME Study Atherosclerosis 170 2003 169 176
6. M.M. Channell, M.L. Paffett, R.B. Devlin, M.C. Madden, and M.J. Campen Circulating factors induce coronary endothelial cell activation following exposure to inhaled diesel exhaust and nitrogen dioxide in humans: evidence from a novel translational in vitro model Toxicol Sci 127 1 2012 179 186
7. S. Timmers, E. Konings, and L. Bilet Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans Cell Metab 14 2011 612 622
8. J. Tome-Carneiro, M. Gonzalvez, M. Larrosa, M.J. Yanez-Gascon, F.J. Garcia-Almagro, and J.A. Ruiz-Ros One-year consumption of a grape nutraceutical containing resveratrol improves the inflammatory and fibrinolytic status of patients in primary prevention of cardiovascular disease Am J Cardiol 110 3 2012 356 363
9. A. Tedgui, and Z. Mallat Cytokines in atherosclerosis: pathogenic and regulatory pathways Physiol Rev 86 2006 515 581